Expression of hepatitis b virus X (HBx) gene is up-regulated by adriamycin at the post-transcriptional level

Biochemical and Biophysical Research Communications

Volumn 296, Issue 5, 2002, Pages 1157-1163

  Yun, Chawon ^a   Lee, Jae Ho ^a   Wang, Jin Hee ^a   Seong, Je Kyung ^b   Hyun Oh, Seung ^b   Yu, Dae Yeul ^c   Cho, Hyeseong ^a  

^a Ajou University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Adriamycin; Gene expression; Half life; HBV; HBx; HBx mRNA stability; HBx protein stability

Indexed keywords

DOXORUBICIN; ENZYME INHIBITOR; MESSENGER RNA; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HALF LIFE TIME; HBX GENE; HEPATITIS B VIRUS; LIVER CANCER; LIVER DISEASE; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; CELL LINE; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DOXORUBICIN; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, VIRAL; KINETICS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RNA STABILITY; RNA, MESSENGER; RNA, VIRAL; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

HEPATITIS B VIRUS; MUS MUSCULUS;

EID: 0036392176     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02058-2     Document Type: Article

References (39)

1. E. Hildt, P.H. Hofschneider, S. Urban, The role of hepatitis B virus (HBV) in the development of hepatocellular carcinoma, Semin. Virol. 7 (1996) 333-347.
2. J.A. Cromlish, Hepatitis B-virus-induced hepatocellular carcinoma: possible roles for HBx, Trends Microbiol. 4 (1996) 270-274.
3. F. Henkler, R. Koshy, Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis, J. Viral Hepatitis 3 (1996) 109-121.
4. Y.D. Yoo, H. Ueda, K. Park, K.C. Flanders, Y.I. Lee, G. Jay, S.J. Kim, Regulation of transforming growth factor-β1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis, J. Clin. Invest. 97 (1996) 388-395.
5. J. Benn, F. Su, M. Doria, R.J. Schneider, Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases, J. Virol. 70 (1996) 4978-4985
6. N.P. Klein, R.J. Schneider, Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras, Mol. Cell. Biol. 17 (1997) 6427-6436.
7. M. Doria, N. Klein, R. Lucito, R.J. Schneider, The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors, EMBO J. 14 (1995) 4747-4757.
8. Y. Lin, H. Tang, T. Nomura, D. Dorjsuren, N. Hayashi, W. Wei, T. Ohta, R. Roeder, S. Murakami, The hepatitis B virus X protein is a co-activator of activated transcription that modulates the transcription machinery and distal binding activators, J. Biol. Chem. 273 (1998) 27097-27103.
9. Y. Lin, T. Nomura, J. Cheong, D. Dorjsuren, K. Iida, S. Murakami, Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5, J. Biol. Chem. 272 (1997) 7132-7139
10. M. Höhne, S. Schaefer, M. Sefer, M.A. Feitelson, D. Paul, W.H. Gerlich, Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA, EMBO J. 9 (1990) 1137-1145.
11. K. Koike, K. Moriya, H. Yotsuyanagi, S. Iino, K. Kurokawa, Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts, J. Clin. Invest. 94 (1994) 44-49.
12. W.L. Shih, M.L. Kuo, S.E. Chuang, A.L. Cheng, S.L. Doong, Hepatitis B virus X protein inhibits transforming growth factor-β-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway, J. Biol. Chem. 275 (2000) 25858-25864
13. J. Diao, A.A. Khine, F. Sarangi, E. Hsu, C. Iorio, L.A. Tibbles, J.R. Woodgett, J. Penninger, C.D. Richardson, X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway, J. Biol. Chem. 276 (2001) 8328-8340.
14. P. Chirillo, S. Pagano, G. Natoli, P.L. Puri, V.L. Burgio, C. Balsano, M. Levrero, The hepatitis B virus X gene induces p53-mediated programmed cell death, Proc. Natl. Acad. Sci. USA 94 (1987) 8162-8167.
15. F. Su, R.J. Schneider, Hepatitis B virus HBx protein sensitizes cell to apoptotic killing by tumor necrosis factor α, Proc. Natl. Acad. Sci. USA 84 (1997) 8744-8749.
16. H. Kim, H. Lee, Y. Yun, X-gene product of hepatitis B virus induces apoptosis in liver cells, J. Biol. Chem. 273 (1998) 381-385
17. F. Bergametti, S. Prigent, B. Luber, A. Benoit, P. Tiollais, A. Sarasin, C. Transy, The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines, Oncogene 18 (1999) 2860-2871
18. K. Koike, K. Moriya, S. Iino, H. Yotsuyanagi, Y. Endo, T. Miyamura, K. Kurokawa, High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice, Hepatology 19 (1994) 810-819.
19. D.Y. Yu, H.B. Moon, J.K. Son, S. Jeong, S.L. Yu, H. Yoon, Y.M. Han, C.S. Lee, J.S. Park, C.H. Lee, B.H. Hyun, S. Murakami, K.K. Lee, Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein, J. Hepatol. 31 (1999) 123-132.
20. S. Schaefer, M. Seifer, T. Grimmsmann, L. Fink, S. Wenderhold, M.W. Hohne, W.H. Gerlich, Properties of tumor suppressor p53 in murine hepatocyte lines transformed by hepatitis B virus X protein, J. Gen. Virol. 79 (1998) 767-777.
21. F. Imazeki, K. Yaginuma, M. Omata, K. Okuda, M. Kobayashi, K. Koike, RNA transcripts of hepatitis B virus in hepatocellular carcinoma, Hepatology 7 (1987) 753-757.
22. Y.M. Jin, C. Yun, C. Park, H.J. Wang, H. Cho, Expression of hepatitis B virus X (HBx) protein is closely correlated with the high periportal inflammatory activity of liver diseases, J. Viral Hepatitis 8 (2001) 322-330.
23. F. Henkler, N. Waseem, M.H. Golding, M.R. Alison, R. Koshy, Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma, Cancer Res. 55 (1995) 6084-6091.
24. Q. Su, C.H. Schroder, W.J. Hofmann, G. Otto, R. Pichimayr, P. Bannasch, Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinoma, Hepatology 27 (1998) 1109-1120.
25. L.G. Guidotti, T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, F.V. Chisari, Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes, Immunity 4 (1996) 25-36.
26. G. Doitsh, Y. Shaul, HBV transcription repression in response to genotoxic stress is p53-dependent and abrogated by pX, Oncogene 18 (1999) 7506-7513.
27. S.W. Lee, Y.M. Lee, S.K. Bae, S. Murakami, Y. Yun, K.W. Kim, Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis, Biochem. Biophys. Res. Commun. 268 (2000) 456-461.
28. C.W. Yun, J.H. Lee, H. Park, Y.M. Jin, S. Park, K. Park, H. Cho, Chemotherapeutic drug, adriamycin, restores the function of p53 protein in hepatitis B virus X (HBx) protein expressing liver cells, Oncogene 19 (2000) 5163-5172.
29. H.H. Marti, W. Risau, Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors, Proc. Natl. Acad. Sci. USA 95 (1998) 15809-15814
30. M.O. Lee, H.J. Kang, H. Cho, E.C. Shin, J.H. Park, S.J. Kim, Hepatitis B virus X protein induced expression of the Nur77 gene, Biochem. Biophys. Res. Commun. 288 (2001) 1162-1168
31. O. Terradillos, T. Pollicino, H. Lecoeur, M. Tripodi, M.L. Gougeon, P. Tiollais, M.A. Buendia, p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro, Oncogene 17 (1998) 2115-2123.
32. H. Lee, Y.H. Lee, Y.S. Huh, H. Moon, Y. Yun, X-gene product antagonizes the p53-mediated inhibition of hepatitis B virus replication through regulation of the pregenomic/core promoter, J. Biol. Chem. 270 (1995) 31405-31412
33. D.A. Dixon, C.D. Kaplan, T.M. Mclntyre, G.A. Zimmerman, S.M. Prescott, Post-transcriptional control of cyclooxygenase-2 gene expression: the role of the 3′-untranslated region, J. Biol. Chem. 275 (2000) 11750-11757.
34. S. Zhou, C.M. Palmera, K.B. Wallace, Doxorubicin-induced persistent oxidative stress to cardiac myocytes, Toxicol. Lett. 121 (2001) 151-157.
35. M. Dandri, J. Petersen, R.J. Stockert, T.M. Harris, C.E. Rogler, Metabolic labeling of woodchuck hepatitis B virus X protein in naturally infected hepatocytes reveals a bimodal half-life and association with the nuclear framework, J. Virol. 72 (1998) 9359-9364.
36. F. Bergametti, D. Sitterlin, C. Transy, Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex, J. Virol. 76 (2002) 6495-6501.
37. Y. Ono, T. Yoshimasu, R. Ashikaga, M. Inoue, H. Shindou, K. Fuji, Y. Araki, Y. Nishimura, Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma, Am. J. Clin. Oncol. 23 (2000) 564-568.
38. H. Suzuki, M. Mori, C. Kawaguchi, M. Adachi, S. Miura, H. Ishii, Serum vascular endothelial growth factor in the course of transcatheter arterial embolization of hepatocellular carcinoma, Int. J. Oncol. 14 (1999) 1087-1090.
39. Y.B. Kim, Y.N. Park, C. Park, Increased proliferation activities of vascular endothelial cells and tumor cells in residual hepatocellular carcinoma following transcatheter arterial embolization, Histopathology 38 (2001) 160-166.